Glycogen storage diseases: An update

被引:23
作者
Gumus, Ersin [1 ]
Ozen, Hasan [1 ,2 ]
机构
[1] Hacettepe Univ, Ihsan Dogramaci Childrens Hosp, Dept Pediat Gastroenterol Hepatol & Nutr, Fac Med, TR-06230 Ankara, Turkiye
[2] Hacettepe Univ, Ihsan Dogramaci Childrens Hosp, Dept Pediat Gastroenterol Hepatol & Nutr, Fac Med, Gevher Nesibe Cad, TR-06230 Ankara, Turkiye
关键词
Glycogen storage disease; Liver; Muscle; Hypoglycemia; PHOSPHORYLASE-KINASE DEFICIENCY; INFLAMMATORY-BOWEL-DISEASE; FANCONI-BICKEL-SYNDROME; BONE-MINERAL DENSITY; LINKED LIVER GLYCOGENOSIS; GLUCOSE-6-PHOSPHATE TRANSLOCASE GENE; DEBRANCHING ENZYME DEFICIENCY; COLONY-STIMULATING FACTORS; SERUM BIOTINIDASE ACTIVITY; POLYGLUCOSAN BODY DISEASE;
D O I
10.3748/wjg.v29.i25.3932
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Glycogen storage diseases (GSDs), also referred to as glycogenoses, are inherited metabolic disorders of glycogen metabolism caused by deficiency of enzymes or transporters involved in the synthesis or degradation of glycogen leading to aberrant storage and/or utilization. The overall estimated GSD incidence is 1 case per 20000-43000 live births. There are over 20 types of GSD including the subtypes. This heterogeneous group of rare diseases represents inborn errors of carbohydrate metabolism and are classified based on the deficient enzyme and affected tissues. GSDs primarily affect liver or muscle or both as glycogen is particularly abundant in these tissues. However, besides liver and skeletal muscle, depending on the affected enzyme and its expression in various tissues, multiorgan involvement including heart, kidney and/or brain may be seen. Although GSDs share similar clinical features to some extent, there is a wide spectrum of clinical phenotypes. Currently, the goal of treatment is to maintain glucose homeostasis by dietary management and the use of uncooked cornstarch. In addition to nutritional interventions, pharmacological treatment, physical and supportive therapies, enzyme replacement therapy (ERT) and organ transplantation are other treatment approaches for both disease manifestations and long-term complications. The lack of a specific therapy for GSDs has prompted efforts to develop new treatment strategies like gene therapy. Since early diagnosis and aggressive treatment are related to better prognosis, physicians should be aware of these conditions and include GSDs in the differential diagnosis of patients with relevant manifestations including fasting hypoglycemia, hepatomegaly, hypertransaminasemia, hyperlipidemia, exercise intolerance, muscle cramps/pain, rhabdomyolysis, and muscle weakness. Here, we aim to provide a comprehensive review of GSDs. This review provides general characteristics of all types of GSDs with a focus on those with liver involvement.
引用
收藏
页码:3932 / 3963
页数:32
相关论文
共 319 条
  • [1] Glycogen storage disease type VI: clinical course and molecular background
    Aeppli, Tim R. J.
    Rymen, Daisy
    Allegri, Gabriella
    Bode, Peter K.
    Haeberle, Johannes
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2020, 179 (03) : 405 - 413
  • [2] Afroze B, 2016, J PEDIATR GENET, V5, P161, DOI [10.1055/s-0036-584360, 10.1055/s-0036-1584360]
  • [3] A case report of acute pancreatitis with glycogen storage disease type IA in an adult patient and review of the literature
    Ai, Jiaoyu
    He, Wenhua
    Huang, Xin
    Wu, Yao
    Lei, Yupeng
    Yu, Chen
    Gorgulu, Kivanc
    Diakopoulos, Kalliope N.
    Lu, Nonghua
    Zhu, Yin
    [J]. MEDICINE, 2020, 99 (42) : E22644
  • [4] Improvement in hypertrophic cardiomyopathy after using a high-fat, high-protein and low-carbohydrate diet in a non-adherent child with glycogen storage disease type IIIa
    Akin, Burcu Kumru
    Hismi, Burcu Ozturk
    Daly, Anne
    [J]. MOLECULAR GENETICS AND METABOLISM REPORTS, 2022, 32
  • [5] Prenatal diagnosis of glycogen storage disease type IV
    Akman, H. Orhan
    Karadimas, Charalampos
    Gyftodimou, Yolanda
    Grigoriadou, Maria
    Kokotas, Haris
    Konstantinidou, Anastasia
    Anninos, Hector
    Patsouris, Efstratios
    Thaker, Harshwardhan M.
    Kaplan, Jeffrey B.
    Besharat, Isaam
    Hatzikonstantinou, Konstantina
    Fotopoulos, Spyridon
    DiMauro, Salvatore
    Petersen, Michael B.
    [J]. PRENATAL DIAGNOSIS, 2006, 26 (10) : 951 - 955
  • [6] Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the γ2-subunit of AMP-Activated protein kinase
    Akman, Hasan O.
    Sampayo, James N.
    Ross, Fiona A.
    Scott, John W.
    Wilson, Gregory
    Benson, Lee
    Bruno, Claudio
    Shanske, Sara
    Hardie, D. Grahame
    Dimauro, Salvatore
    [J]. PEDIATRIC RESEARCH, 2007, 62 (04) : 499 - 504
  • [7] Novel PHKG2 mutation causing GSD IX with prominent liver disease: report of three cases and review of literature
    Albash, Buthainah
    Imtiaz, Faiqa
    Al-Zaidan, Hamad
    Al-Manea, Hadeel
    Banemai, Mohammed
    Allam, R.
    Al-Suheel, Ali
    Al-Owain, Mohammed
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2014, 173 (05) : 647 - 653
  • [8] Glycogen storage disease type IV presenting as hydrops fetalis
    Alegria, A
    Martins, E
    Dias, M
    Cunha, A
    Cardoso, ML
    Maire, I
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (03) : 330 - 332
  • [9] Long Term G-CSF-Induced Remission of Ulcerative Colitis-Like Inflammatory Bowel Disease in a Patient With Glycogen Storage Disease Ib and Evaluation of Associated Neutrophil Function
    Alsultan, Abdulrahman
    Sokol, Ronald J.
    Lovell, Mark A.
    Thurman, Gail
    Ambruso, Daniel R.
    [J]. PEDIATRIC BLOOD & CANCER, 2010, 55 (07) : 1410 - 1413
  • [10] Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II:: Results of a phase I/II clinical trial
    Amalfitano, A
    Bengur, AR
    Morse, RP
    Majure, JM
    Case, LE
    Veerling, DL
    Mackey, J
    Kishnani, P
    Smith, W
    McVie-Wylie, A
    Sullivan, JA
    Hoganson, GE
    Phillips, JA
    Schaefer, GB
    Charrow, J
    Ware, RE
    Bossen, EH
    Chen, YT
    [J]. GENETICS IN MEDICINE, 2001, 3 (02) : 132 - 138